These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30854449)

  • 1. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
    Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
    Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow.
    Gurbani S; Weinberg B; Cooper L; Mellon E; Schreibmann E; Sheriff S; Maudsley A; Goryawala M; Shu HK; Shim H
    Tomography; 2019 Mar; 5(1):184-191. PubMed ID: 30854456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
    Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
    J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastoma.
    Kim MM; Aryal MP; Sun Y; Parmar HA; Li P; Schipper M; Wahl DR; Lawrence TS; Cao Y
    Neuro Oncol; 2021 Sep; 23(9):1537-1546. PubMed ID: 33599755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
    Popp I; Bott S; Mix M; Oehlke O; Schimek-Jasch T; Nieder C; Nestle U; Bock M; Yuh WTC; Meyer PT; Weber WA; Urbach H; Mader I; Grosu AL
    Radiother Oncol; 2019 Jan; 130():121-131. PubMed ID: 30219612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma.
    Wahl DR; Kim MM; Aryal MP; Hartman H; Lawrence TS; Schipper MJ; Parmar HA; Cao Y
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):757-764. PubMed ID: 29980414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy.
    Peeken JC; Molina-Romero M; Diehl C; Menze BH; Straube C; Meyer B; Zimmer C; Wiestler B; Combs SE
    Radiother Oncol; 2019 Sep; 138():166-172. PubMed ID: 31302391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group.
    Wee CW; Sung W; Kang HC; Cho KH; Han TJ; Jeong BK; Jeong JU; Kim H; Kim IA; Kim JH; Kim SH; Kim S; Lee DS; Lee MY; Lim DH; Park HL; Suh CO; Yoon SM; Kim IH
    Radiat Oncol; 2015 Jul; 10():137. PubMed ID: 26134973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
    Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
    J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Recurrent Glioblastoma from Delayed Radiation Necrosis by Using Voxel-based Multiparametric Analysis of MR Imaging Data.
    Yoon RG; Kim HS; Koh MJ; Shim WH; Jung SC; Kim SJ; Kim JH
    Radiology; 2017 Oct; 285(1):206-213. PubMed ID: 28535120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator.
    Bolcaen J; Descamps B; Boterberg T; Vanhove C; Goethals I
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
    Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
    J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation.
    Deng Z; Xu X; Garzon-Muvdi T; Xia Y; Kim E; Belcaid Z; Luksik A; Maxwell R; Choi J; Wang H; Yu J; Iordachita I; Lim M; Wong JW; Wang KK
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):612-620. PubMed ID: 31738948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.